Langenselbold, Germany

Kornelia Voß

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Steinhagen, DE (2020)
  • Langenselbold, DE (2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kornelia Voß: Innovator in L-Lysine Production

Introduction

Kornelia Voß is a prominent inventor based in Langenselbold, Germany. She has made significant contributions to the field of biotechnology, particularly in the production of L-lysine, an essential amino acid. With a total of 2 patents, her work has garnered attention in both academic and industrial circles.

Latest Patents

Kornelia Voß's latest patents focus on innovative methods for the fermentative production of L-lysine. One of her patents describes a method utilizing an L-lysine excreting bacterium of the species that has a completely or partly deleted WHIB4 gene. This method enhances the efficiency of L-lysine production. Another patent outlines a method for producing L-lysine using a bacterium that contains a polynucleotide encoding a mutated polypeptide with the assumed function of an acyltransferase, hydrolase, alpha/beta hydrolase, or a pimeloyl-ACP methyl ester esterase. These advancements are crucial for improving the yield and sustainability of L-lysine production processes.

Career Highlights

Kornelia Voß is currently employed at Evonik Operations GmbH, a leading company in specialty chemicals. Her role at the company allows her to apply her innovative ideas in a practical setting, contributing to the advancement of biotechnological applications.

Collaborations

Throughout her career, Kornelia has collaborated with notable colleagues, including Frank Schneider and Georg Thierbach. These partnerships have facilitated the exchange of ideas and fostered a collaborative environment for innovation.

Conclusion

Kornelia Voß is a trailblazer in the field of L-lysine production, with her patents reflecting her commitment to advancing biotechnological methods. Her work at Evonik Operations GmbH and collaborations with esteemed colleagues further highlight her impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…